Considering the higher percentage of smokers and ex-smokers in the SMARCA4-UT population, it should not be surprising that the most frequent co-occurring mutations in these patients are similar to those detected in NSCLC patients who are also smokers. This evidence concerns the gene SMARCA4 and non-small cell lung carcinoma.